Advanced Enzyme

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE837H01020
NSEID: ADVENZYMES
BSEID: 540025

INR

311.35

-2.6 (-0.83%)

BSENSE

Dec 05

BSE+NSE Vol: 49.65 k

{
  "main_header": {
    "sid": 1000007,
    "name": "Advanced Enzyme",
    "stock_name": "Advanced Enzyme",
    "full_name": "Advanced Enzyme Technologies Ltd",
    "name_url": "stocks-analysis/advanced-enzyme",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "311.35",
    "chg": -2.6,
    "chgp": "-0.83%",
    "dir": -1,
    "prev_price": "313.95",
    "mcapval": "3,484.84 Cr",
    "mcap": "Small Cap",
    "scripcode": 540025,
    "symbol": "ADVENZYMES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE837H01020",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "49.65 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/advanced-enzyme-1000007-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Advanced Enzyme Technologies: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/advanced-enzyme-technologies-faces-technical-momentum-shift-amid-mixed-market-signals-3740288",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AdvancedEnzymeT_technicaldot_3740288.png",
        "date": "2025-12-02 08:10:24",
        "description": "Advanced Enzyme Technologies has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a combination of technical indicators reflecting contrasting signals across weekly and monthly timeframes, suggesting a complex market assessment for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Why is Advanced Enzyme falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-advanced-enzyme-fallingrising-3726943",
        "imagepath": "",
        "date": "2025-11-25 01:18:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been under pressure for the past five consecutive trading sessions, accumulating a loss of 7.17% over the week. This decline is notably sharper than the marginal 0.06% drop in the Sensex during the same period, indicating company-specific factors influencing investor sentiment. Intraday, the stock touched a low of ₹309.95, marking a 2.22% dip from its previous close. While the broader chemicals sector fell by 2.07%, Advanced Enzyme marginally outperformed its sector peers today by 0.69%, suggesting some resilience amid sector-wide weakness.</p>\n<p>Technically, the stock price remains above its 200-day moving average, a long-term support indicator, but is trading below its short- and medium-term averages including the 5-da..."
      },
      {
        "title": "Advanced Enzyme Technologies: Analytical Perspective Shift Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/advanced-enzyme-technologies-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3723948",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AdvancedEnzymeT_mojoScore_3723948.png",
        "date": "2025-11-24 08:08:27",
        "description": "Advanced Enzyme Technologies has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. Despite some positive quarterly financial results, the company’s long-term growth trajectory and technical signals present a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Advanced Enzyme Technologies Faces Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/advanced-enzyme-technologies-faces-technical-momentum-shift-amid-bearish-indicators-3723871",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AdvancedEnzymeT_technicaldot_3723871.png",
        "date": "2025-11-24 08:05:16",
        "description": "Advanced Enzyme Technologies has experienced a notable shift in its price momentum and technical indicators, reflecting a complex market assessment. The stock’s recent movement reveals a transition from a mildly bullish trend to a sideways pattern, with key technical signals presenting a blend of bearish and bullish cues across different timeframes."
      },
      {
        "title": "How has been the historical performance of Advanced Enzyme?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-advanced-enzyme-3721736",
        "imagepath": "",
        "date": "2025-11-21 22:47:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth Trajectory</strong></p>\n<p>Advanced Enzyme’s net sales have shown a robust upward trend, rising from ₹419.59 crores in March 2019 to ₹636.91 crores by March 2025. This represents a compound growth trajectory reflecting the company’s expanding market presence and operational scale. Total operating income mirrored this growth, with no other operating income reported during this period, indicating core business activities as the primary revenue source.</p>\n<p>Profitability metrics reveal a nuanced picture. Operating profit before other income (PBDIT excl OI) peaked at ₹231.61 crores in March 2021 but moderated to ₹194.44 crores by March 2025. Including other income, operating profit (PBDIT) followed a similar pattern, reaching ₹240.46 crores in 2021 before settling at ..."
      },
      {
        "title": "Advanced Enzyme Technologies Reports Strong Sales Growth Amid Long-Term Profit Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/advanced-enzyme-technologies-stock-rating-upgraded-to-hold-amid-positive-sales-growth-3696689",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AdvancedEnzymeT_mojoScore_3696689.png",
        "date": "2025-11-13 08:20:00",
        "description": "Advanced Enzyme Technologies has recently adjusted its evaluation, reflecting a shift in its stock's technical landscape. The company reported a 26.30% increase in net sales for Q2 FY25-26, alongside strong operating cash flow and PBDIT figures. However, it faces long-term growth challenges, with a slight decline in annual operating profit over five years."
      },
      {
        "title": "Is Advanced Enzyme technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-advanced-enzyme-technically-bullish-or-bearish-3696371",
        "imagepath": "",
        "date": "2025-11-13 08:14:54",
        "description": "As of 12 November 2025, the technical trend has changed from sideways to mildly bullish. The current stance is mildly bullish, driven primarily by the daily moving averages indicating bullish momentum. However, the weekly MACD and KST are bearish, which suggests caution. The monthly RSI shows bullishness, but the overall monthly indicators, including Bollinger Bands and Dow Theory, are mildly bearish. The mixed signals across different time frames indicate a complex situation, but the recent trend change and daily bullish indicators support a mildly bullish outlook...."
      },
      {
        "title": "Advanced Enzyme Technologies Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/advanced-enzyme-technologies-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-price-increase-3696604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AdvancedEnzymeT_technicaldot_3696604.png",
        "date": "2025-11-13 08:09:43",
        "description": "Advanced Enzyme Technologies, a small-cap firm in the Pharmaceuticals and Biotechnology sector, has recently revised its evaluation amid changing market conditions. The stock has shown a notable weekly return, outperforming the Sensex, while technical indicators present a mixed outlook, reflecting both bullish and bearish trends across different time frames."
      },
      {
        "title": "How has been the historical performance of Advanced Enzyme?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-advanced-enzyme-3695446",
        "imagepath": "",
        "date": "2025-11-13 00:25:12",
        "description": "Answer:\nThe historical performance of Advanced Enzyme shows a steady growth in net sales and profits over the years, with some fluctuations in specific metrics.\n\nBreakdown:\nAdvanced Enzyme's net sales increased from 419.59 Cr in March 2019 to 636.91 Cr in March 2025, reflecting a consistent upward trend. Total operating income followed a similar trajectory, rising from 419.59 Cr in March 2019 to 636.91 Cr in March 2025. However, total expenditure also grew, reaching 442.47 Cr in March 2025, up from 237.67 Cr in March 2019. Operating profit (PBDIT) peaked at 240.46 Cr in March 2021 but saw a decline to 227.48 Cr by March 2025. Profit before tax showed some variability, with a high of 210.13 Cr in March 2021 and a slight decrease to 187.36 Cr in March 2025. Profit after tax was 133.97 Cr in March 2025, down from 151.29 Cr in March 2021. The company's total assets grew from 971.18 Cr in March 2020 to 1,611.15 ..."
      }
    ],
    "total": 238,
    "sid": "1000007",
    "stock_news_url": "https://www.marketsmojo.com/news/advanced-enzyme-technologies-1000007"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "17-Nov-2025",
      "details": "Please find enclosed herewith transcript of the earnings conference call held on November 12 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "13-Nov-2025",
      "details": "Audio recording of Conference Call for the Un-audited Financial Results for the quarter and half year ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Nov-2025",
      "details": "Please find enclosed herewith news paper publication with respect to the unaudited financial results for the quarter and half year ended September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Advanced Enzyme Technologies Ltd has declared <strong>60%</strong> dividend, ex-date: 23 Jul 25",
          "dt": "2025-07-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Advanced Enzyme Technologies Ltd has announced <strong>2:10</strong> stock split, ex-date: 25 May 17",
          "dt": "2017-05-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Advanced Enzyme Technologies: Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:10:24

Advanced Enzyme Technologies has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a combination of technical indicators reflecting contrasting signals across weekly and monthly timeframes, suggesting a complex market assessment for the pharmaceutical and biotechnology company.

Why is Advanced Enzyme falling/rising?

2025-11-25 01:18:19

Recent Price Movement and Market Context

The stock has been under pressure for the past five consecutive trading sessions, accumulating a loss of 7.17% over the week. This decline is notably sharper than the marginal 0.06% drop in the Sensex during the same period, indicating company-specific factors influencing investor sentiment. Intraday, the stock touched a low of ₹309.95, marking a 2.22% dip from its previous close. While the broader chemicals sector fell by 2.07%, Advanced Enzyme marginally outperformed its sector peers today by 0.69%, suggesting some resilience amid sector-wide weakness.

Technically, the stock price remains above its 200-day moving average, a long-term support indicator, but is trading below its short- and medium-term averages including the 5-da...

Advanced Enzyme Technologies: Analytical Perspective Shift Amid Mixed Financial and Technical Signals

2025-11-24 08:08:27

Advanced Enzyme Technologies has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. Despite some positive quarterly financial results, the company’s long-term growth trajectory and technical signals present a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Advanced Enzyme Technologies Faces Mixed Technical Signals Amid Price Momentum Shift

2025-11-24 08:05:16

Advanced Enzyme Technologies has experienced a notable shift in its price momentum and technical indicators, reflecting a complex market assessment. The stock’s recent movement reveals a transition from a mildly bullish trend to a sideways pattern, with key technical signals presenting a blend of bearish and bullish cues across different timeframes.

How has been the historical performance of Advanced Enzyme?

2025-11-21 22:47:20

Revenue and Profit Growth Trajectory

Advanced Enzyme’s net sales have shown a robust upward trend, rising from ₹419.59 crores in March 2019 to ₹636.91 crores by March 2025. This represents a compound growth trajectory reflecting the company’s expanding market presence and operational scale. Total operating income mirrored this growth, with no other operating income reported during this period, indicating core business activities as the primary revenue source.

Profitability metrics reveal a nuanced picture. Operating profit before other income (PBDIT excl OI) peaked at ₹231.61 crores in March 2021 but moderated to ₹194.44 crores by March 2025. Including other income, operating profit (PBDIT) followed a similar pattern, reaching ₹240.46 crores in 2021 before settling at ...

Advanced Enzyme Technologies Reports Strong Sales Growth Amid Long-Term Profit Challenges

2025-11-13 08:20:00

Advanced Enzyme Technologies has recently adjusted its evaluation, reflecting a shift in its stock's technical landscape. The company reported a 26.30% increase in net sales for Q2 FY25-26, alongside strong operating cash flow and PBDIT figures. However, it faces long-term growth challenges, with a slight decline in annual operating profit over five years.

Is Advanced Enzyme technically bullish or bearish?

2025-11-13 08:14:54

As of 12 November 2025, the technical trend has changed from sideways to mildly bullish. The current stance is mildly bullish, driven primarily by the daily moving averages indicating bullish momentum. However, the weekly MACD and KST are bearish, which suggests caution. The monthly RSI shows bullishness, but the overall monthly indicators, including Bollinger Bands and Dow Theory, are mildly bearish. The mixed signals across different time frames indicate a complex situation, but the recent trend change and daily bullish indicators support a mildly bullish outlook....

Advanced Enzyme Technologies Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-11-13 08:09:43

Advanced Enzyme Technologies, a small-cap firm in the Pharmaceuticals and Biotechnology sector, has recently revised its evaluation amid changing market conditions. The stock has shown a notable weekly return, outperforming the Sensex, while technical indicators present a mixed outlook, reflecting both bullish and bearish trends across different time frames.

How has been the historical performance of Advanced Enzyme?

2025-11-13 00:25:12

Answer: The historical performance of Advanced Enzyme shows a steady growth in net sales and profits over the years, with some fluctuations in specific metrics. Breakdown: Advanced Enzyme's net sales increased from 419.59 Cr in March 2019 to 636.91 Cr in March 2025, reflecting a consistent upward trend. Total operating income followed a similar trajectory, rising from 419.59 Cr in March 2019 to 636.91 Cr in March 2025. However, total expenditure also grew, reaching 442.47 Cr in March 2025, up from 237.67 Cr in March 2019. Operating profit (PBDIT) peaked at 240.46 Cr in March 2021 but saw a decline to 227.48 Cr by March 2025. Profit before tax showed some variability, with a high of 210.13 Cr in March 2021 and a slight decrease to 187.36 Cr in March 2025. Profit after tax was 133.97 Cr in March 2025, down from 151.29 Cr in March 2021. The company's total assets grew from 971.18 Cr in March 2020 to 1,611.15 ...

View All News

Announcement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

17-Nov-2025 | Source : BSE

Please find enclosed herewith transcript of the earnings conference call held on November 12 2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

13-Nov-2025 | Source : BSE

Audio recording of Conference Call for the Un-audited Financial Results for the quarter and half year ended September 30 2025

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Nov-2025 | Source : BSE

Please find enclosed herewith news paper publication with respect to the unaudited financial results for the quarter and half year ended September 30 2025.